These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6158065)

  • 21. An examination of possible interactions between zimelidine, a serotonin uptake inhibitor, and ethanol ingested conjointly in human subjects.
    Brown ZW; Amit Z; Sutherland A; Rockman G; Selvaggi N; Ogren SO
    Neurosci Lett; 1981 Dec; 27(3):351-5. PubMed ID: 6460207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind comparison of zimelidine and desipramine in endogenous depression.
    Lingjaerde O; Bratfos O; Bratlid T; Haug JO
    Acta Psychiatr Scand; 1983 Jul; 68(1):22-30. PubMed ID: 6225313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endorphin levels in cerebrospinal fluid of patients with postoperative and chronic pain.
    Puig MM; Laorden ML; Miralles FS; Olaso MJ
    Anesthesiology; 1982 Jul; 57(1):1-4. PubMed ID: 7091714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre- and postsynaptic effects of zimelidine and norzimelidine on the serotoninergic system: single cell studies in the rat.
    de Montigny C; Blier P; Caillé G; Kouassi E
    Acta Psychiatr Scand Suppl; 1981; 290():79-90. PubMed ID: 6452807
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term treatment with zimelidine leads to a reduction in 5-hydroxytryptamine neurotransmission within the central nervous system of the mouse and rat.
    Fuxe K; Ogren SO; Agnati LF; Eneroth P; Holm AC; Andersson K
    Neurosci Lett; 1981 Jan; 21(1):57-62. PubMed ID: 6259561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obsessive-compulsive disorder and serotonin: is there a connection?
    Insel TR; Mueller EA; Alterman I; Linnoila M; Murphy DL
    Biol Psychiatry; 1985 Nov; 20(11):1174-88. PubMed ID: 2413912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diclofenac increases beta-endorphin plasma concentrations.
    Martini A; Bondiolotti GP; Sacerdote P; Pierro L; Picotti GB; Panerai AE; Restelli L; Zancaner F; Monza G
    J Int Med Res; 1984; 12(2):92-5. PubMed ID: 6202572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. I. Clinical findings.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Jul; 66(1):50-65. PubMed ID: 6214925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute effects of zimelidine and alaproclate, two inhibitors of serotonin uptake, on neuroendocrine function.
    Syvälahti E; Eneroth P; Ross SB
    Psychiatry Res; 1979 Oct; 1(2):111-20. PubMed ID: 121774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of acute doses of zimelidine on REM sleep in rats.
    Reyes RB; Hill SY; Kupfer DJ
    Psychopharmacology (Berl); 1983; 80(3):214-6. PubMed ID: 6225137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of amitriptyline and zimelidine in combination with ethanol.
    Scott DB; Fagan D; Tiplady B
    Psychopharmacology (Berl); 1982; 76(3):209-11. PubMed ID: 6212962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-aggressive effect of zimelidine in isolated mice.
    Ogren SO; Holm AC; Renyi AL; Ross SB
    Acta Pharmacol Toxicol (Copenh); 1980 Jul; 47(1):71-4. PubMed ID: 6446833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Personality traits in chronic pain patients related to endorphin levels in cerebrospinal fluid.
    Johansson F; Almay BG; von Knorring L; Terenius L; Aström M
    Psychiatry Res; 1979 Dec; 1(3):231-9. PubMed ID: 298351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Levels of 5-HIAA and beta-endorphin in CSF after intrathecal morphine].
    González Navarro A; Zimman Mansfeld H; Ortiz-González JM; Molinero Aparicio T; González Hernández MJ; Ferrero Fernandez B
    Arch Neurobiol (Madr); 1985; 48(4):211-3. PubMed ID: 2416296
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of serotonin uptake inhibition by zimelidine on hypothalamic-pituitary-adrenal activity.
    Holsboer F; Müller OA; Winter K; Doerr HG; Sippell WG
    Psychopharmacology (Berl); 1983; 80(1):85-7. PubMed ID: 6306711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zimelidine: a placebo-controlled trial in depression.
    Norman TR; Burrows GD; Marriott PF; McIntyre IM; Davies BM; Moore RG
    Psychiatry Res; 1983 Feb; 8(2):95-103. PubMed ID: 6222387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular effects of zimelidine and other antidepressant in conscious rats.
    Lindbom LO; Forsberg T
    Acta Psychiatr Scand Suppl; 1981; 290():380-4. PubMed ID: 6452801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of fluoxetine and zimelidine on the uptake of 5-hydroxytryptamine and tryptamine by cortical slices and on responses of cortical neurones to stimulation of the nucleus raphe medianus.
    Jones RS; Broadbent J
    Eur J Pharmacol; 1982 Jul; 81(4):681-5. PubMed ID: 6214414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma levels of zimelidine and norzimelidine in endogenous depression.
    Hansen LB; Thomsen IS; Vestergård P; Larsen NE; Hvidberg EF
    Psychopharmacology (Berl); 1980; 69(2):157-60. PubMed ID: 6450427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute changes in cerebrospinal fluid 5-HIAA following oral paroxetine challenge in healthy humans.
    Carpenter LL; Anderson GM; Siniscalchi JM; Chappell PB; Price LH
    Neuropsychopharmacology; 2003 Feb; 28(2):339-47. PubMed ID: 12589387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.